Therapy management application for haemophilia patients successfully passes recertification according to EuroPriSe.
Germany based StatConsult Gesellschaft für klinische und Versorgungsforschung mbH is awarded with the European Privacy Seal for its IT-based service Haemoassist® 2 once again.
Haemoassist® 2 is a smart-phone based therapy management application for haemophilia patients and their physicians. It consists of an electronic patient diary (application) in interaction with a web based monitoring-interface for the attending physicians as well as a pharmacy module. Patients may not only use Haemoassist via the smartphone app, but also via a dedicated web interface.
The re-evaluation was performed by EuroPriSe Legal Expert Jörg Joachim Schlißke and by EuroPriSe Technical Expert Tobias Mielke. It took place on the basis of the EuroPriSe Criteria Catalogue for IT-products and IT-based Services (v201701). The evaluators concluded that Haemoassist continues to meet all applicable EuroPriSe requirements. All changes that had been made to the service since the previous recertification in 04/2019 were taken into account during the re-evaluation.
Further information about the 2022 recertification is available here.